These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12842602)

  • 1. The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers.
    Smyth HD
    Adv Drug Deliv Rev; 2003 Jul; 55(7):807-28. PubMed ID: 12842602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propellant-driven metered-dose inhalers for pulmonary drug delivery.
    Smyth HD
    Expert Opin Drug Deliv; 2005 Jan; 2(1):53-74. PubMed ID: 16296735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers.
    D'Sa D; Chan HK
    Curr Pharm Des; 2015; 21(27):3955-65. PubMed ID: 26290200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
    Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
    Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principles of metered-dose inhaler design.
    Newman SP
    Respir Care; 2005 Sep; 50(9):1177-90. PubMed ID: 16122401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers.
    Smyth HD; Beck VP; Williams D; Hickey AJ
    AAPS PharmSciTech; 2004 Feb; 5(1):E7. PubMed ID: 15198528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New analytical techniques to facilitate preformulation screening in propellant systems.
    Mogalian E; Kuehl PJ; Myrdal PB
    Int J Pharm; 2007 Aug; 340(1-2):223-9. PubMed ID: 17498897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers.
    Traini D; Young PM; Rogueda P; Price R
    Pharm Res; 2007 Jan; 24(1):125-35. PubMed ID: 17103336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the systemic pharmacodynamic effects and pharmacokinetics of salmeterol delivered by CFC propellant and non-CFC propellant metered dose inhalers in healthy subjects.
    Kempsford R; Handel M; Mehta R; De Silva M; Daley-Yates P
    Respir Med; 2005 Apr; 99 Suppl A():S11-9. PubMed ID: 15777604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Formulation Factors on the Aerosol Performance of Suspension and Solution Metered Dose Inhalers: A Systematic Approach.
    Sheth P; Sandell D; Conti DS; Holt JT; Hickey AJ; Saluja B
    AAPS J; 2017 Sep; 19(5):1396-1410. PubMed ID: 28593514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding pressurized metered dose inhaler performance.
    Ivey JW; Vehring R; Finlay WH
    Expert Opin Drug Deliv; 2015 Jun; 12(6):901-16. PubMed ID: 25496601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel formulation technique for metered dose inhaler (MDI) suspensions.
    Steckel H; Wehle S
    Int J Pharm; 2004 Oct; 284(1-2):75-82. PubMed ID: 15454299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canister valve and actuator deposition in metered dose inhalers formulated with low-GWP propellants.
    Duke DJ; Rao L; Kastengren A; Myatt B; Cocks P; Stein S; Marasini N; Ong HX; Young P
    Int J Pharm; 2023 Dec; 648():123569. PubMed ID: 37925043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in metered dose inhaler technology: formulation development.
    Myrdal PB; Sheth P; Stein SW
    AAPS PharmSciTech; 2014 Apr; 15(2):434-55. PubMed ID: 24452499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pMDI formulations for pulmonary delivery of proteins.
    Li HY; Seville PC
    Int J Pharm; 2010 Jan; 385(1-2):73-8. PubMed ID: 19854252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
    Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
    Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
    Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulite: a simple solution to a difficult problem.
    Lewis DA; Ganderton D; Meakin BJ; Brambilla G
    Respiration; 2005; 72 Suppl 1():3-5. PubMed ID: 15915006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The formulation of a pressurized metered dose inhaler containing theophylline for inhalation.
    Zhu B; Haghi M; Goud M; Young PM; Traini D
    Eur J Pharm Sci; 2015 Aug; 76():68-72. PubMed ID: 25956075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.